ProMIS Neurosciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|
Revenue | $0 | $0 | $6 |
Gross Profit | -11 | ||
EBITDA | -4,434 | -2,623 | -3,676 |
EBIT | -2,713 | -3,683 | |
Net Income | 9,275 | -2,623 | -3,635 |
Net Change In Cash | 0 | 0 | 6 |
Free Cash Flow | -6,671 | -1,421 | -10,291 |
Cash | 21,536 | 992 | 3,382 |
Basic Shares | 30,067 | 19,770 | 19,533 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $8 | $8 | $1 |
Gross Profit | -10,444 | -21,781 | -5,843 | -3,181 |
EBITDA | -17,809 | -29,879 | -9,327 | -4,428 |
EBIT | -17,837 | -29,895 | -9,373 | -4,440 |
Net Income | -17,506 | -12,744 | -9,657 | -4,440 |
Net Change In Cash | 0 | 8 | 8 | 1 |
Free Cash Flow | -14,367 | -17,035 | -9,290 | -3,500 |
Cash | 16,692 | 7,955 | 21,426 | 1,028 |
Basic Shares | 12,292 | 7,502 | 5,785 | 4,759 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.43 |
2024-06-30 | -$0.13 |
2024-03-31 | -$0.19 |
2023-12-31 | -$0.29 |
